HuD mRNA levels are also significantly higher in NB patient cohorts (Fig. S1A and B) and cell lines (Fig. 1B) compared with other patient cancer types (using the same HuD probe and changes normalized). This evidence concerns the gene ELAVL4 and neuroblastoma.